A detailed history of Legacy Capital Wealth Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Legacy Capital Wealth Partners, LLC holds 628 shares of LLY stock, worth $551,070. This represents 0.15% of its overall portfolio holdings.

Number of Shares
628
Previous 8,456 92.57%
Holding current value
$551,070
Previous $6.58 Million 91.37%
% of portfolio
0.15%
Previous 4.28%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$724.87 - $909.04 $5.67 Million - $7.12 Million
-7,828 Reduced 92.57%
628 $568,000
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $4.69 Million - $6.28 Million
7,925 Added 1492.47%
8,456 $6.58 Million
Q4 2023

Feb 05, 2024

SELL
$525.19 - $619.13 $33,612 - $39,624
-64 Reduced 10.76%
531 $309,000
Q3 2023

Oct 16, 2023

BUY
$434.7 - $599.3 $258,646 - $356,583
595 New
595 $319,000
Q1 2023

May 10, 2023

BUY
$310.63 - $364.82 $181,718 - $213,419
585 New
585 $200,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $834B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Legacy Capital Wealth Partners, LLC Portfolio

Follow Legacy Capital Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Capital Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Capital Wealth Partners, LLC with notifications on news.